Diabetic control after total pancreatectomy

Digestive and Liver Disease

Volumn 38, Issue 6, 2006, Pages 415-419

  Jethwa, P ^a   Sodergren, M ^a   Lala, A ^a   Webber, J ^a   Buckels, J A C ^a   Bramhall, S R ^a   Mirza, D F ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Diabetes; Glycosylated haemoglobin; Malignancy; Pancreatitis; Total pancreatectomy

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CONSULTATION; CONTROLLED STUDY; DEATH; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDICAL RECORD; PANCREAS ADENOMA; PANCREAS CANCER; PANCREAS DISEASE; PANCREAS RESECTION; PANCREATITIS; TELEPHONE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATITIS, CHRONIC; RETROSPECTIVE STUDIES;

EID: 33748514347     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.01.022     Document Type: Article

References (27)

1. Sohn T.A., Campbell K.A., Pitt H.A., Sauter P.K., Coleman J.A., Lillemo K.D., et al. Quality of life and long-term survival after surgery for chronic pancreatitis. J Gastrointest Surg 4 (2000) 355-364 [discussion 364-5]
2. Kiviluoto T., Schroder T., Karonen S.L., Kuusi T., Lempinen M., and Taskinen M.R. Glycemic control and serum lipoproteins after total pancreatectomy. Ann Clin Res 17 (1985) 110-115
3. Dresler C.M., Fortner J.G., McDermott K., and Bajorunas D.R. Metabolic consequences of (regional) total pancreatectomy. Ann Surg 214 (1991) 131-140
4. Sauvanet A. Functional results of pancreatic surgery. Rev Prat 52 (2002) 1572-1575
5. Duron F., and Duron J.J. Pancreatectomy and diabetes. Ann Chir 53 (1999) 406-411
6. Karmann H., Laurent F., and Mialhe P. Pancreatic hormones disappearance after total pancreatectomy in the duck: correlation between plasma glucagon and glucose. Horm Metab Res 19 (1987) 538-541
7. Unger R.H. Glucagon physiology and pathophysiology. N Engl J Med 285 (1971) 443-449
8. Slezak L.A., and Andersen D.K. Pancreatic resection: effects on glucose metabolism. World J Surg 25 (2001) 452-460
9. Seymour N.E., Brunicardi F.C., Chaiken R.L., Lebovitz H.E., Chance R.E., Gingerich R.L., et al. Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man. Surgery 104 (1988) 119-129
10. Nosadini R., del Prato S., Tiengo A., Duner E., Toffolo G., Cobelli C., et al. Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes 31 4 Pt 1 (1982) 346-355
11. Economic and Social Research Council (ESRC). Stratification of socio-economic status (2005). www.esrc.ac.uk
12. Duffy J.P., and Reber H.A. Surgical treatment of chronic pancreatitis. J Hepatobiliary Pancreat Surg 9 (2002) 659-668
13. Cooperman A.M. Surgery and chronic pancreatitis. Surg Clin North Am 81 (2001) 431-455
14. Heise J.W., Katoh M., Luthen R., and Roher H.D. Long-term results following different extent of resection in chronic pancreatitis. Hepatogastroenterology 48 (2001) 864-868
15. Gall F.P., Gebhardt C., and Zirngibl H. Chronic pancreatitis. Results of 116 consecutive, partial duodenopancreatectomies with duct occlusion. Fortschr Med 99 (1981) 1967-1972
16. Forssmann K., Schirr K., Schmid M., Schwall G., Silbernik D., Singer M.V., et al. Postoperative follow-up in patients with partial Whipple duodenopancreatectomy for chronic pancreatitis. Z Gastroenterol 35 (1997) 1071-1080
17. Piorkowski R.J., Blievernicht S.W., Lawrence Jr. W., Madariaga J., Horsley III J.S., Neifeld J.P., et al. Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period. Am J Surg 143 (1982) 189-193
18. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
19. The DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90 (1991) 450-459
20. Bilo H.J., and Gans R.O. Hypertensive patients and diabetes: a high-risk population. J Cardiovasc Pharmacol 32 Suppl. 2 (1998) S1-S8
21. Luno J., Garcia de Vinuesa S., Gomez-Campdera F., Lorenzo I., and Valderrabano F. Effects of antihypertensive therapy on progression of diabetic nephropathy. Kidney Int Suppl 68 (1998) S112-S119
22. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. J Am Med Assoc 2003;290:2159-67.
23. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 321 (2000) 405-412
24. Bilous R.W. End-stage renal failure and management of diabetes. Diabet Med 21 Suppl. 1 (2004) 12-14
25. Ruggenenti P., Gaspari F., Perna A., and Remuzzi G. Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 h urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. Br Med J 316 (1998) 504-509
26. Dahl-Jorgensen K. Diabetic microangiopathy. Acta Paediatr Suppl 425 (1998) 31-34
27. Bolli G., de Feo P., Compagnucci P., Cartechini M.G., Angeletti G., Santeusanio F., et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32 (1983) 134-141